BUSILVEX

Swiss trademark · 495788 · Word mark · In force

Register entry

Registration number
495788
Application number
11785/2001
Status
In force
Type
Word mark
Filed
Dec 14, 2001
Registered
Mar 14, 2002
Published
Mar 28, 2002
Protected until
Dec 14, 2031
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Erzeugnisse und Präparate für Behandlungen bei Knochenmarktransplantationen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 16, 2022

    Agent’s address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  2. Sep 29, 2021

    Agent removed

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich (removed)

    Published in Swissreg on 29.09.2021

  3. Sep 29, 2021

    Agent entered

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 29.09.2021

  4. Sep 29, 2021

    Renewed

    Published in Swissreg on 29.09.2021

  5. Jun 7, 2011

    Renewed

    Published in Swissreg on 07.06.2011

  6. Jun 23, 2008

    Transferred

    Owner
    PDL BioPharma, Inc., 34801 Campus Drive, Fremont, CA 94555, USA → Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, Japan

    Published in the SOGC no. 119 of 23.06.2008

  7. Aug 20, 2007

    Agent’s address changed

    Representative
    Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich → Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in the SOGC no. 159 of 20.08.2007

  8. Jul 3, 2006

    Transferred

    Owner
    ESP Pharma, Inc., 2035 Lincoln Highway, Suite 2150, Edison, New Jersey 08817, USA → ESP Pharma Holding Company, Inc., 34801 Campus Drive, Fremont, CA 94555, USA
    Representative
    Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich (removed)

    Published in the SOGC no. 126 of 03.07.2006

5 earlier entries
  1. Jul 3, 2006

    Transferred

    Owner
    ESP Pharma Holding Company, Inc., 34801 Campus Drive, Fremont, CA 94555, USA → Protein Design Labs, Inc., 34801 Campus Drive, Fremont, CA 94555, USA

    Published in the SOGC no. 126 of 03.07.2006

  2. Jul 3, 2006

    Holder’s address changed

    Owner
    Protein Design Labs, Inc., 34801 Campus Drive, Fremont, CA 94555, USA → PDL BioPharma, Inc., 34801 Campus Drive, Fremont, CA 94555, USA

    Published in the SOGC no. 126 of 03.07.2006

  3. Jul 3, 2006

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich

    Published in the SOGC no. 126 of 03.07.2006

  4. May 24, 2004

    Transferred

    Owner
    Orphan Medical, Inc., 13911 Ridgedale Drive,, Suite 250, Minnetonka (MN 55305), USA → ESP Pharma, Inc., 2035 Lincoln Highway, Suite 2150, Edison, New Jersey 08817, USA

    Published in the SOGC no. 98 of 24.05.2004

  5. Mar 28, 2002

    Registered

    Published in the SOGC no. 61 of 28.03.2002

Parties

Holder

Otsuka Pharmaceutical Co., Ltd.

2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JP

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.